Real‐world safety and efficacy of sofosbuvir and ledipasvir for elderly patients

BACKGROUND AND AIM: In September 2015, sofosbuvir and ledipasvir were approved for clinical use in Japan for patients infected with genotype 1 hepatitis C virus. We conducted a postmarketing prospective cohort study to elucidate the safety and efficacy of this therapy in a real‐world setting. METHOD...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JGH Open
Main Authors: Tamai, Hideyuki, Shingaki, Naoki, Ida, Yoshiyuki, Shimizu, Ryo, Maeshima, Shuya, Okamura, Junpei, Kawashima, Akira, Nakao, Taisei, Hara, Takeshi, Matsutani, Hiroyoshi, Nishikawa, Izumi, Higashi, Katsuhiko
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley Publishing Asia Pty Ltd 2018
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6308062/
https://ncbi.nlm.nih.gov/pubmed/30619941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jgh3.12088
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados